Suppr超能文献

羟吡啶硫酮类似物作为金属酶抑制作用的类药药效团。

Isosteres of hydroxypyridinethione as drug-like pharmacophores for metalloenzyme inhibition.

机构信息

Department of Chemistry and Biochemistry, University of California, La Jolla, San Diego, CA, 92093, USA.

出版信息

J Biol Inorg Chem. 2018 Oct;23(7):1129-1138. doi: 10.1007/s00775-018-1593-1. Epub 2018 Jul 12.

Abstract

Hydroxypyridinethiones (HOPTOs) are strong ligands for metal ions and potentially useful pharmacophores for inhibiting metalloenzymes relevant to human disease. However, HOPTOs have been sparingly used in drug discovery efforts due, in part, to concerns that this scaffold will act as a promiscuous, non-selective metalloenzyme inhibitor, as well as possess poor pharmacokinetics (PK), which may undermine drug candidates containing this functional group. To advance HOPTOs as a useful pharmacophore for metalloenzyme inhibitors, a library of 22 HOPTO isostere compounds has been synthesized and investigated. This library demonstrates that it is possible to maintain the core metal-binding pharmacophore (MBP) while generating diversity in structure, electronics, and PK properties. This HOPTO library has been screened against a set of four different metalloenzymes, demonstrating that while the same metal-binding donor atoms are maintained, there is a wide range of activity between metalloenzyme targets. Overall, this work shows that HOPTO isosteres are useful MBPs and valuable scaffolds for metalloenzyme inhibitors.

摘要

羟吡啶硫酮(HOPTOs)是金属离子的强配体,也是抑制与人类疾病相关的金属酶的潜在有用药效团。然而,由于担心该支架将作为一种混杂的、非选择性的金属酶抑制剂,以及具有较差的药代动力学(PK),因此 HOPTOs 在药物发现工作中很少被使用,这可能会破坏含有该功能团的候选药物。为了将 HOPTOs 推进为金属酶抑制剂的有用药效团,已经合成并研究了 22 种 HOPTO 等排化合物库。该库证明,在保持核心金属结合药效团(MBP)的同时,结构、电子和 PK 性质可以产生多样性。该 HOPTO 库已经针对四组不同的金属酶进行了筛选,表明虽然保持了相同的金属结合供体原子,但金属酶靶标之间的活性范围很广。总的来说,这项工作表明 HOPTO 等排物是有用的 MBP 和金属酶抑制剂的有价值的支架。

相似文献

1
Isosteres of hydroxypyridinethione as drug-like pharmacophores for metalloenzyme inhibition.
J Biol Inorg Chem. 2018 Oct;23(7):1129-1138. doi: 10.1007/s00775-018-1593-1. Epub 2018 Jul 12.
2
Effect of donor atom identity on metal-binding pharmacophore coordination.
J Biol Inorg Chem. 2017 Jun;22(4):605-613. doi: 10.1007/s00775-017-1454-3. Epub 2017 Apr 7.
3
Hydroxypyridinethione Inhibitors of Human Insulin-Degrading Enzyme.
ChemMedChem. 2021 Jun 7;16(11):1775-1787. doi: 10.1002/cmdc.202100111. Epub 2021 Mar 31.
4
Metal-Binding Isosteres as New Scaffolds for Metalloenzyme Inhibitors.
Inorg Chem. 2018 Aug 6;57(15):9538-9543. doi: 10.1021/acs.inorgchem.8b01632. Epub 2018 Jul 16.
5
Targeting Metalloenzymes by Boron-Containing Metal-Binding Pharmacophores.
J Med Chem. 2021 Dec 23;64(24):17706-17727. doi: 10.1021/acs.jmedchem.1c01691. Epub 2021 Dec 7.
6
A Bioinorganic Approach to Fragment-Based Drug Discovery Targeting Metalloenzymes.
Acc Chem Res. 2017 Aug 15;50(8):2007-2016. doi: 10.1021/acs.accounts.7b00242. Epub 2017 Jul 17.
7
Developing Metal-Binding Isosteres of 8-Hydroxyquinoline as Metalloenzyme Inhibitor Scaffolds.
Inorg Chem. 2022 May 16;61(19):7631-7641. doi: 10.1021/acs.inorgchem.2c00891. Epub 2022 May 4.
8
Synthesis, structure and spectroscopy of new thiopyrone and hydroxypyridinethione transition-metal complexes.
Dalton Trans. 2005 Aug 7(15):2588-96. doi: 10.1039/b505034k. Epub 2005 Jun 23.
9
Exploring the influence of the protein environment on metal-binding pharmacophores.
J Med Chem. 2014 Aug 28;57(16):7126-35. doi: 10.1021/jm500984b. Epub 2014 Aug 19.
10
Structure-Activity Relationships in Metal-Binding Pharmacophores for Influenza Endonuclease.
J Med Chem. 2018 Nov 21;61(22):10206-10217. doi: 10.1021/acs.jmedchem.8b01363. Epub 2018 Oct 31.

引用本文的文献

1
Sulfur-Phenolate Exchange as a Mild, Fast, and High-Yielding Method toward the Synthesis of Sulfonamides.
Org Lett. 2023 Feb 10;25(5):788-793. doi: 10.1021/acs.orglett.2c04292. Epub 2023 Jan 31.
2
Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors.
RSC Med Chem. 2022 Jul 29;13(10):1127-1149. doi: 10.1039/d2md00175f. eCollection 2022 Oct 19.
3
Hydroxypyridinethione Inhibitors of Human Insulin-Degrading Enzyme.
ChemMedChem. 2021 Jun 7;16(11):1775-1787. doi: 10.1002/cmdc.202100111. Epub 2021 Mar 31.
5
Identification of Adenosine Deaminase Inhibitors by Metal-binding Pharmacophore Screening.
ChemMedChem. 2020 Nov 18;15(22):2151-2156. doi: 10.1002/cmdc.202000271. Epub 2020 Oct 14.
6
A Cephalosporin Prochelator Inhibits New Delhi Metallo-β-lactamase 1 without Removing Zinc.
ACS Infect Dis. 2020 May 8;6(5):1264-1272. doi: 10.1021/acsinfecdis.0c00083. Epub 2020 Apr 29.
7
Dual-Pharmacophore Pyrithione-Containing Cephalosporins Kill Both Replicating and Nonreplicating .
ACS Infect Dis. 2019 Aug 9;5(8):1433-1445. doi: 10.1021/acsinfecdis.9b00112. Epub 2019 Jun 11.
8
Investigation of Dipicolinic Acid Isosteres for the Inhibition of Metallo-β-Lactamases.
ChemMedChem. 2019 Jul 3;14(13):1271-1282. doi: 10.1002/cmdc.201900172. Epub 2019 May 24.
9
Alison Butler: papers in celebration of her 2018 ACS Alfred Bader Award in Bioorganic or Bioinorganic Chemistry.
J Biol Inorg Chem. 2021 May;26(2-3):375-377. doi: 10.1007/s00775-018-1618-9.

本文引用的文献

1
Inhibitors of metallo-β-lactamases.
Curr Opin Microbiol. 2017 Oct;39:96-105. doi: 10.1016/j.mib.2017.10.026. Epub 2017 Nov 16.
2
Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives.
J Med Chem. 2017 May 11;60(9):3533-3551. doi: 10.1021/acs.jmedchem.6b01227. Epub 2017 Feb 7.
4
Fragment-Based Identification of Influenza Endonuclease Inhibitors.
J Med Chem. 2016 Jul 14;59(13):6444-54. doi: 10.1021/acs.jmedchem.6b00628. Epub 2016 Jun 22.
5
Structure Property Relationships of Carboxylic Acid Isosteres.
J Med Chem. 2016 Apr 14;59(7):3183-203. doi: 10.1021/acs.jmedchem.5b01963. Epub 2016 Mar 30.
7
Investigating the Selectivity of Metalloenzyme Inhibitors in the Presence of Competing Metalloproteins.
ChemMedChem. 2015 Oct;10(10):1733-8. doi: 10.1002/cmdc.201500293. Epub 2015 Aug 25.
8
Metalloprotein Inhibitors for the Treatment of Human Diseases.
Curr Top Med Chem. 2016;16(4):384-96. doi: 10.2174/1568026615666150813145218.
9
Characterisation of selected active agents regarding pKa values, solubility concentrations and pH profiles by SiriusT3.
Eur J Pharm Biopharm. 2015 May;92:155-70. doi: 10.1016/j.ejpb.2015.02.028. Epub 2015 Mar 7.
10
Chemistry: Chemical con artists foil drug discovery.
Nature. 2014 Sep 25;513(7519):481-3. doi: 10.1038/513481a.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验